日韩精品欧美专区,国产v综合v亚洲欧美久久,jizz性欧美2,国产精品色婷婷

Ask the Experts: Documenting Vaccination

Results (26)

CDC’s “General Best Practices for Immunization” still states that a patient’s self-report of a history of vaccination without any documentation can generally be accepted as proof of vaccination only for influenza and pneumococcal polysaccharide vaccines. The ACIP recommendation for administering a primary series of inactivated polio vaccine to an adult also indicates that adults may generally be presumed to have had a primary series of polio vaccine unless there is a specific reason to believe that they have not been vaccinated against polio. See the Adult Vaccination section at www.cdc.gov/vaccines/hcp/imz-best-practices/vaccination-programs.html#cdc_report_pub_study_section_5-adult-vaccination.

Last reviewed: February 16, 2025

The Food and Drug Administration (FDA) website has a list of all vaccines licensed for use in the United States at www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833. Note that some licensed vaccines may not currently be distributed in the United States (for example, the Cervarix brand of HPV vaccine and the Zostavax brand of shingles vaccine).

Last reviewed: February 16, 2025

One way to handle this is to indicate if the vaccination was given either in the “upper” or “lower” portion of the injection area selected (e.g., DTaP: right thigh, upper; Hib: right thigh, lower; or PCV13: left thigh, upper; HepB: left thigh, lower). It is helpful if everyone in your office or clinic uses the same sites for each vaccine. Use of a standardized site map can facilitate this. Here are some helpful site maps for different ages so you can record where shots were given:

For infants and toddlers: www.eziz.org/PDF/IMM-718.pdf

For adults: eziz.org/assets/docs/ADA/IMM-718A.pdf

Last reviewed: February 16, 2025

Vaccination providers frequently encounter people who do not have adequate documentation of vaccinations. Providers should only accept written, dated records as evidence of vaccination. CDC recommends that, with the exception of influenza and pneumococcal polysaccharide vaccines, self-reported doses of vaccine without written documentation should generally not be accepted. The ACIP recommendation for administering a primary series of inactivated polio vaccine to an adult also indicates that adults may generally be presumed to have had a primary series of polio vaccine unless there is a specific reason to believe that they have not been vaccinated against polio. Professional judgment is also required when assessing adults without a record of hepatitis B vaccination: vaccination rates for hepatitis B in childhood have been high since the late 1990s and routine infant HepB vaccination began in 1991. In the absence of a record or of screening results demonstrating evidence of hepatitis B immunity or resolved or chronic infection, if there is any suspicion that the adult was unvaccinated, then vaccination is recommended.

An attempt to locate missing records should be made whenever possible by contacting previous healthcare providers, reviewing state or local immunization information systems (IIS, registries), and searching for a personally held record. However, if records cannot be located or are unavailable anywhere because of the patient’s circumstances, people without adequate documentation should be considered susceptible and should be started on the age-appropriate vaccination schedule. Serologic testing for immunity is an alternative to vaccination for certain antigens (e.g., measles, rubella, or hepatitis A).

In general, although it is not ideal, receiving extra doses of vaccine poses no medical problem. Receiving excessive doses of tetanus toxoid (DTaP, DT, Tdap, or Td) can increase the risk of a local adverse reaction, however. For details, consult the CDC’s? “Best Practices for Immunization” chapter titled Timing and Spacing of Immunobiologics, available at?www.cdc.gov/vaccines/hcp/imz-best-practices/timing-spacing-immunobiologics.html.

Last reviewed: February 16, 2025

If a provider suspects an invalid vaccination, including those from persons vaccinated outside the U.S., one of two approaches can be taken. Repeating the vaccinations is an acceptable option. Doing so is generally safe and avoids the need to obtain and interpret serologic tests. If avoiding unnecessary injections is desired, judicious use of serologic testing might be helpful in determining which immunizations are needed. This may be particularly helpful in determining tetanus and diphtheria antitoxin levels for children whose records indicate 3 or more doses of DTP or DTaP. This issue is discussed in detail in the CDC’s “General Best Practices for Immunization” chapter titled Special Situations, and summarized in Table 9-1, available at?www.cdc.gov/vaccines/hcp/imz-best-practices/special-situations.html.

Last reviewed: February 16, 2025

Healthcare providers (or other covered entities) may share immunization information with schools or daycare facilities, without authorization, if permitted or required by state law. These state laws would not be preempted by the HIPAA Privacy Rule [45 CFR 160.203(c)].

Last reviewed: February 16, 2025

There is no federal law requiring a refusal form. Several major medical organizations, including the American Academy of Pediatrics, have stated that healthcare providers may decide it is in their best interest to formally document a parent’s refusal to accept vaccination for their (minor) child. To read a discussion on this topic and to access a prototype refusal form, see “Record of Vaccine Declination” that can be accessed at www.immunize.org/catg.d/p4059.pdf.

Last reviewed: February 16, 2025

As of 2021, every state has an IIS that is capable of accepting and storing immunization records on individuals of all ages. To find out the status of the IIS in your state you should contact your state IIS program or your state immunization program. CDC maintains a listing of contact information for all state IIS programs at?www.cdc.gov/iis/contacts-locate-records/.

Last reviewed: February 16, 2025

Patient-held cards are an important part of a person’s medical history. The person may move to another state or need medical care at a facility within or outside the state without access to the IIS in which their records are documented, and the personal record may be the only vaccination record available.

Last reviewed: February 16, 2025

The National Childhood Vaccine Injury Act (NCVIA), enacted in 1986, set forth 3 basic requirements for all vaccination providers, which are:

  • Providers must give the patient (or parent/legal representative of a minor) a copy of the relevant federal “Vaccine Information Statement” (VIS) for the vaccine they are about to receive.
  • Providers must record certain information about the vaccine(s) administered in the patient’s medical record or a permanent office log.
  • Providers must document any adverse event following the vaccination that the patient experiences and that becomes known to the provider, whether or not it is felt to be caused by the vaccine, and submit the report to the Vaccine Adverse Event Reporting System (VAERS) at https://vaers.hhs.gov.
Last reviewed: February 16, 2025

It is important to know the federal requirements for documenting the vaccines administered to your patients. The requirements are defined in the National Childhood Vaccine Injury Act (NCVIA) enacted in 1986. The law applies to all routinely recommended childhood vaccines, and vaccines recommended during pregnancy (except COVID-19 and RSV), regardless of the age of the patient receiving the vaccines.

The RSV preventive antibody, nirsevimab (Beyfortus, Sanofi) is not a vaccine and not covered by the NCVIA, but a VIS-equivalent, known as an immunization information sheet (IIS), should be provided to the caregiver of an infant receiving nirsevimab.

The following information must be documented on the patient’s paper or electronic medical record or on a permanent office log when a vaccine covered by the NCVIA is given, and is recommended when any vaccine is administered:

  1. The vaccine manufacturer
  2. The lot number of the vaccine
  3. The date the vaccine is administered
  4. The name, office address, and title of the healthcare provider administering the vaccine
  5. The Vaccine Information Statement (VIS) edition date located in the lower right corner on the back of the VIS; when administering combination vaccines, all applicable VISs should be given and the individual VIS edition dates recorded
  6. The date the VIS is given to the patient, parent, or guardian

The federally required information should be both permanent and accessible.

Federal law does not require a parent, patient, or guardian to sign a consent form in order to receive a vaccination; providing them with the appropriate VIS(s), IIS, or Emergency Use Authorization (EUA) Fact Sheet (where applicable) and answering their questions is sufficient under federal law.

Last reviewed: February 16, 2025

NCVIA requirements apply to diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), varicella, seasonal influenza (inactivated and live attenuated), pneumococcal conjugate, meningococcal, rotavirus, and human papillomavirus (HPV) vaccine.

Last reviewed: February 16, 2025

In response to public health emergencies and security dangers, the government supports the development of countermeasures. A countermeasure is a vaccine, medication, device, or other item used to prevent, diagnose, or treat a public health emergency or a security threat.

The Countermeasures Injury Compensation Program (CICP, www.hrsa.gov/cicp) provides compensation for covered serious injuries or deaths that occur as the result of the administration or use of certain countermeasures. Compensation may include unreimbursed medical expenses (expenses that health insurance did not cover), lost employment income, and the survivor death benefit. The Secretary of the Department of Health and Human Services has issued federal declarations under the Public Readiness and Emergency Preparedness Act (PREP Act) that list the countermeasures covered by the CICP. For a list of covered countermeasures and for information about filing a claim, visit www.hrsa.gov/cicp/covered-countermeasures.

Last reviewed: February 16, 2025

The National Childhood Vaccine Injury Act requires that a VIS must be given to parents, legal representatives, or adult patients before administering the vaccine. A VIS must be provided prior to each dose, not just the first dose. Providers should be sure they are using the most current version of each VIS. Current VISs and their dates are available from on the CDC’s website at?www.cdc.gov/vaccines/hcp/vis/index.html?and from Immunize.org’s website at?www.immunize.org/vaccines/vis/about-vis/. Immunize.org offers translations of VISs in dozens of languages. If a translation of a current VIS is unavailable, a usable translation of an earlier English language version is posted when available. Translations should be provided in addition to, not in place of, the current federal VIS (in English).

Last reviewed: February 16, 2025

Instructions on the use of VISs and many additional items are available on the CDC website at?www.cdc.gov/vaccines/hcp/vis/index.html?or from your state immunization program. You can also visit Immunize.org’s website at?www.immunize.org/vaccines/vis/about-vis/ for links to important documents about the use of VISs.

Last reviewed: February 16, 2025

An interim VIS can sometimes be released soon after licensure of the vaccine or after the official vote by ACIP is taken. The interim VIS is not replaced with a final version until the ACIP recommendations have been published and the new VIS has been developed according to legally mandated procedures.

Last reviewed: February 16, 2025

Yes. The National Childhood Vaccine Injury Act requires that a VIS be given to people of any age before they receive a dose of any vaccine included in the Act. Tetanus and diphtheria toxoids (and pertussis vaccine) are included in the Act. If the patient is unaccompanied and unable to clearly read and understand the information in the VIS (e.g., the patient is unconscious), this should be noted in the patient’s chart.

Last reviewed: February 16, 2025

Your solution will meet the spirit of the federal law, as long as you make sure to encourage the patient (or parent) to take home a paper copy of the VIS and to refer to it if needed (e.g., if they need to know what to do if there is an adverse event or how to contact VAERS).

Immunize.org offers another option with its document containing QR codes for all VISs, available at www.immunize.org/wp-content/uploads/catg.d/p2093.pdf. A patient may scan the QR code with their phone to download the current VIS. Provision of an electronic copy of the VIS in this manner complies with federal law.

Last reviewed: February 16, 2025

VISs are required to be given and documented when any vaccine covered by the National Childhood Vaccine Injury Act (NCVIA) is given to a person of any age in any setting, including influenza vaccine. CDC recommends that VISs should be given and documented any time any vaccine is administered, regardless of the recipient’s age and setting.

Current VISs are available from the CDC’s website at?www.cdc.gov/vaccines/hcp/vis/index.html?and from the Immunize.org website at www.immunize.org/translations/, where you will also find many VIS translations in other languages.

Immunize.org offers another option with its document containing QR codes for all VISs available at www.immunize.org/wp-content/uploads/catg.d/p2093.pdf. It also offers a document with QR code links to all available translations of the widely used injectable influenza vaccine VIS (www.immunize.org/wp-content/uploads/catg.d/p2092.pdf) which is especially helpful in busy influenza vaccination clinics. A vaccine recipient or parent of a minor child may scan the QR code with their phone to download the current VIS. Provision of an electronic copy of the VIS in this manner complies with federal law.

Last reviewed: February 16, 2025

If a patient clicks a link or scans a QR code to access an electronic copy of the VIS before vaccination, that complies with federal law to provide the VIS. Immunize.org provides clinical resources displaying QR codes linking to VISs that may be printed out and used in clinics on its “VIS-related resources” page: www.immunize.org/clinical/topic/vis/.

Last reviewed: February 16, 2025

No. There is no federal requirement for signed consent for any dose of a vaccine licensed for use by the FDA. The federal requirement is to provide all adult patients or parents/legal representatives of minor children with the appropriate VIS (or Emergency Use Authorization Fact Sheet, when applicable) for each dose of vaccine administered. Some clinics, agencies, and/or state immunization programs may have requirements for signatures. Contact information for your state health department is available at? www.immunize.org/official-guidance/state-policies/state-resources/.

Last reviewed: February 16, 2025

CDC currently has no plans to develop VISs for combination vaccines such as Pediarix, Twinrix, Kinrix, Quadracel, Pentacel, or Penbraya. When administering these combination vaccines, use the VISs for all component vaccines. For certain combination vaccines given to children, you can use the multi-vaccine VIS (which includes DTaP, Hib, HepB, polio, and PCV) and check the appropriate box(es), just as you would if you were administering the individual vaccines. If the multi-vaccine VIS is unavailable, you should use the individual vaccine VISs. A VIS was developed for MMRV (ProQuad, by Merck) because of its unique adverse reaction profile.

Last reviewed: February 16, 2025

Not necessarily. Providers do not need to discard their existing printed VIS stocks when nothing but the VIS format has been changed. CDC posts information on its website to alert healthcare providers when the older version of a VIS should not be used. This information is available on CDC’s web section titled “What’s New with VISs”, available at www.cdc.gov/vaccines/hcp/vis/what-is-new.html.

Last reviewed: February 16, 2025

CDC began adding barcodes to VISs in 2012. The barcode is intended to save time and prevent documentation errors by allowing immunization providers to scan the name and edition date of the VIS, information required to be documented in the permanent record of immunization, into an electronic medical record, immunization information system, or other electronic database. Scanning the barcode instead of manually recording the information is optional but can be helpful.

Using 2D barcodes requires a 2D barcode scanner and software that is programmed to accept and process data contained in the VIS barcodes. Providers may continue to use any VISs without barcodes as long as the VIS content is otherwise the same. For more information about using barcodes, visit www.cdc.gov/vaccines/hcp/about-vis/barcodes-faq.html.

Last reviewed: February 16, 2025

CDC publishes VISs in English only; all translations have been developed by others. To access all currently available VISs in dozens of languages, go to Immunize.org’s website at? www.immunize.org/translations/.

Last reviewed: February 16, 2025

An Emergency Use Authorization (EUA) fact sheet for vaccine recipients and caregivers is provided to a vaccine recipient (or caregiver) when FDA allows the use of an unapproved vaccine during a public health emergency. For information about EUAs for vaccines, see www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained. The manufacturer prepares an EUA fact sheet for healthcare providers (in place of the package insert found in licensed and approved vaccines), and an EUA fact sheet for recipients and caregivers that informs the recipient, to the extent possible, of the potential benefits and risks of the vaccine, that the recipient has the option to refuse or accept the vaccine, and any available alternatives to the vaccine. An EUA fact sheet should be provided to the recipient before administration and documented in the shot record, as is done with a VIS, when a vaccine is administered under EUA conditions.

Last reviewed: February 16, 2025

This page was updated on .

日韩精品欧美专区,国产v综合v亚洲欧美久久,jizz性欧美2,国产精品色婷婷
日本怡春院一区二区| 91在线观看高清| 久久九九全国免费| 欧美日本在线观看| 亚洲男女一区二区三区| 欧美日韩1234| 国内精品写真在线观看| 国产亚洲成aⅴ人片在线观看| 这里只有精品99re| 久久99久久久久久久久久久| 欧美videofree性高清杂交| 欧美不卡一区二区三区| 精品视频全国免费看| 99久久99久久精品国产片果冻| 麻豆免费看一区二区三区| 国产伦精品一区二区三区免费| 91香蕉视频污| 九九久久精品视频| 亚洲一区二区在线视频| 亚洲综合在线五月| 亚洲午夜三级在线| 亚洲嫩草精品久久| 国产精品久久看| 色吊一区二区三区| 国产一区欧美一区| 成人深夜在线观看| av一二三不卡影片| 亚洲精品乱码久久久久久久久| 国产乱子轮精品视频| 久久免费国产精品| 成人福利视频在线看| 91精品国产福利| 欧美国产综合一区二区| 激情综合色丁香一区二区| 国产999精品久久| 国产精品高潮呻吟| 欧美丰满少妇xxxxx高潮对白| 精品久久久久久最新网址| 91在线视频免费观看| 久久久久久99久久久精品网站| 国产精品久久久久久久久果冻传媒| 一区二区三区日韩在线观看| 99麻豆久久久国产精品免费| 国产精品美女久久久久aⅴ国产馆| 国产麻豆精品视频| av亚洲精华国产精华| 日韩免费视频一区二区| 国产精品中文字幕一区二区三区| 亚洲gay无套男同| 欧美最猛性xxxxx直播| 国产欧美精品一区| 欧美成人a∨高清免费观看| 国产在线视频精品一区| 国产成人综合亚洲网站| 婷婷亚洲久悠悠色悠在线播放| 日本韩国精品一区二区在线观看| 精品蜜桃在线看| 91捆绑美女网站| 欧美高清dvd| 中文字幕欧美激情一区| 欧美亚洲图片小说| 久久久高清一区二区三区| 国产成人综合在线观看| www.66久久| 久久综合久久综合久久综合| 日本韩国欧美三级| 亚洲在线观看免费视频| 色偷偷久久一区二区三区| 欧美激情在线免费观看| 久久噜噜亚洲综合| 国产精品伦一区二区三级视频| 成人18精品视频| 91在线porny国产在线看| 亚洲色图欧洲色图| 日韩一区二区视频| 欧美精品v日韩精品v韩国精品v| 激情伊人五月天久久综合| 亚洲天堂av一区| 亚洲成av人片在线| 91激情在线视频| 国产精品嫩草影院av蜜臀| 久久精品视频在线免费观看| 狠狠色伊人亚洲综合成人| 日韩久久一区二区| 久久99久久精品欧美| 九九**精品视频免费播放| 欧美精品一区二区在线观看| 日韩欧美的一区二区| 盗摄精品av一区二区三区| 亚洲成人免费视| 精品无人区卡一卡二卡三乱码免费卡| 欧美精品一区二| 国产亚洲精品bt天堂精选| 精品久久国产97色综合| 中文字幕一区二区三区不卡在线| 亚洲高清不卡在线| 免费看精品久久片| 国产精品污污网站在线观看| 91麻豆国产福利精品| 久久精品一区二区三区不卡| 黄网站免费久久| 中文字幕欧美日本乱码一线二线| 一区二区三区色| 亚洲免费观看高清完整版在线观看熊| 欧美系列亚洲系列| 中文字幕第一区综合| 精品国产乱码久久久久久浪潮| 亚洲成人精品一区二区| 麻豆精品在线播放| 国产高清无密码一区二区三区| 欧美日韩一级二级三级| 中文字幕一区二区三区色视频| 国产精品拍天天在线| 欧美日韩成人激情| 黄页网站大全一区二区| 欧美日韩一区在线| 亚洲色图制服诱惑| 久久成人免费日本黄色| 欧美三级视频在线观看| 精品国产一区二区三区久久影院| 99久久综合国产精品| 亚洲精品国产精华液| 欧美一卡2卡3卡4卡| 国产最新精品免费| 久久久久国产精品麻豆ai换脸| 国产丝袜美腿一区二区三区| 欧美日韩久久久久久| 国产精品一区免费视频| 欧美一区二区三区视频| 久久精品日产第一区二区三区高清版| 国产成人免费视频网站高清观看视频| 在线播放欧美女士性生活| 亚洲成人精品一区| 在线观看av一区| 91精品国产综合久久福利软件| 日本不卡的三区四区五区| 97久久超碰国产精品电影| 欧美tickling网站挠脚心| 黄网站免费久久| 在线视频一区二区免费| 欧美日韩一区二区电影| 日韩精品一区二区三区老鸭窝| 色综合久久中文字幕综合网| 中文在线资源观看网站视频免费不卡| 国产精品国产三级国产aⅴ中文| 欧美日韩国产欧美日美国产精品| 亚洲精品日韩综合观看成人91| 欧洲国产伦久久久久久久| 高清国产一区二区| 欧美精品丝袜中出| 久久国产精品色| 亚洲精品免费一二三区| 爽好多水快深点欧美视频| 亚洲最大色网站| 日韩三级视频在线观看| 成人午夜激情在线| 91精品办公室少妇高潮对白| 精品一区二区在线观看| 亚洲人吸女人奶水| 亚洲人成在线播放网站岛国| 成人一级片在线观看| 懂色av中文字幕一区二区三区| 久久影音资源网| 国产成人99久久亚洲综合精品| 亚洲精品成人在线| 91精品国产综合久久久久久漫画| 韩国成人精品a∨在线观看| 日韩av成人高清| 一区二区三区四区视频精品免费| 99精品国产91久久久久久| 久久成人av少妇免费| 久久九九全国免费| 亚洲最大成人网4388xx| 久久久一区二区三区捆绑**| 91丝袜高跟美女视频| 国产精品乱码一区二区三区软件| 国产精品中文有码| 国产精品久久久久永久免费观看| 久久你懂得1024| 北条麻妃国产九九精品视频| 激情久久久久久久久久久久久久久久| 国产乱码精品一区二区三区忘忧草| 久久久蜜臀国产一区二区| 一个色综合网站| 国产女人18水真多18精品一级做| 成人一区二区三区中文字幕| 麻豆91精品视频| 欧美午夜理伦三级在线观看| 久久精品一区二区三区四区| 欧美在线观看视频一区二区| 国产精品久线观看视频| 色八戒一区二区三区| 国产精品丝袜黑色高跟| 日韩精品一区二区三区四区视频| 午夜一区二区三区在线观看| 欧美精品一区二区三区蜜桃视频| 一区二区不卡在线视频 午夜欧美不卡在| 久久国产视频网| 777色狠狠一区二区三区| 日韩片之四级片|